Review
Published on 03 Dec 2024
Delineation of erythropoietic intermediates by flow cytometry
Frontiers in Hematology
doi 10.3389/frhem.2024.1496916
- 369 views
Volumes
116 Publications
Volume 3 - 2024
Original Research
Published on 02 Dec 2024
Rare cell-based liquid biopsy for improved measurement of low-grade chronic inflammation
Frontiers in Hematology
doi 10.3389/frhem.2024.1472609
- 236 views
Original Research
Published on 26 Nov 2024
Exploring the regenerative capacity of the spleen following irradiation
Frontiers in Hematology
doi 10.3389/frhem.2024.1396672
- 266 views
Original Research
Published on 22 Nov 2024
Distinct clinico-genomic factors drive outcomes in patients with myelofibrosis and disease-related anemia
Frontiers in Hematology
doi 10.3389/frhem.2024.1492680
- 263 views
Case Report
Published on 15 Nov 2024
Late onset pancytopenia post chimeric antigen receptor T cell therapy triggered by a COVID-19 vaccination: a case report
Frontiers in Hematology
doi 10.3389/frhem.2024.1435584
- 398 views
Case Report
Published on 13 Nov 2024
Case report: VEXAS syndrome and literature review
Frontiers in Hematology
doi 10.3389/frhem.2024.1480436
- 289 views
Mini Review
Accepted on 05 Nov 2024
Not just for mature audiences: myeloproliferative neoplasms in children, adolescents, and young adults
Frontiers in Hematology
doi 10.3389/frhem.2024.1483322
Review
Published on 29 Oct 2024
Early T-cell precursor acute lymphoblastic leukemia: diagnostic pitfalls, genomic alteration, novel therapeutics, and minimal residual disease monitoring
Frontiers in Hematology
doi 10.3389/frhem.2024.1463410
- 1,153 views
Editorial
Published on 18 Oct 2024
Editorial: Editors’ showcase: red cells, iron and erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2024.1457513
- 247 views
Perspective
Published on 18 Oct 2024
The CHIP-clinic as the catalyst of preventive medicine
Frontiers in Hematology
doi 10.3389/frhem.2024.1459154
- 643 views
Review
Published on 07 Oct 2024
Clonal evolution: a landmark of MPN evolution
Frontiers in Hematology
doi 10.3389/frhem.2024.1473920
- 786 views
Review
Published on 27 Sep 2024
Recent advancements in gene therapy for sickle cell disease and β-thalassemia
Frontiers in Hematology
doi 10.3389/frhem.2024.1468952
- 3,000 views
Review
Published on 25 Sep 2024
Dissecting dormancy and quiescence in hematopoietic stem cells
Frontiers in Hematology
doi 10.3389/frhem.2024.1401713
- 738 views
Original Research
Published on 11 Sep 2024
Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell transplantation
Frontiers in Hematology
doi 10.3389/frhem.2024.1438233
- 522 views
Editorial
Published on 29 Aug 2024
Editorial: Rising stars in hematopoiesis and stem cells 2023
Frontiers in Hematology
doi 10.3389/frhem.2024.1477997
- 401 views
Perspective
Published on 27 Aug 2024
Sickle cell disease: a comparative perspective on global and national initiatives
Frontiers in Hematology
doi 10.3389/frhem.2024.1457158
- 1,588 views